These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

837 related articles for article (PubMed ID: 18506843)

  • 1. Toll-like receptors and adaptor molecules in liver disease: update.
    Seki E; Brenner DA
    Hepatology; 2008 Jul; 48(1):322-35. PubMed ID: 18506843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor and RIG-I-like receptor signaling.
    Kawai T; Akira S
    Ann N Y Acad Sci; 2008 Nov; 1143():1-20. PubMed ID: 19076341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway.
    Lang T; Lo C; Skinner N; Locarnini S; Visvanathan K; Mansell A
    J Hepatol; 2011 Oct; 55(4):762-9. PubMed ID: 21334391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR3 signaling in a hepatoma cell line is skewed towards apoptosis.
    Khvalevsky E; Rivkin L; Rachmilewitz J; Galun E; Giladi H
    J Cell Biochem; 2007 Apr; 100(5):1301-12. PubMed ID: 17243100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic zebrafish reporter lines reveal conserved Toll-like receptor signaling potential in embryonic myeloid leukocytes and adult immune cell lineages.
    Hall C; Flores MV; Chien A; Davidson A; Crosier K; Crosier P
    J Leukoc Biol; 2009 May; 85(5):751-65. PubMed ID: 19218482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6.
    Häcker H; Redecke V; Blagoev B; Kratchmarova I; Hsu LC; Wang GG; Kamps MP; Raz E; Wagner H; Häcker G; Mann M; Karin M
    Nature; 2006 Jan; 439(7073):204-7. PubMed ID: 16306937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling.
    Carty M; Goodbody R; Schröder M; Stack J; Moynagh PN; Bowie AG
    Nat Immunol; 2006 Oct; 7(10):1074-81. PubMed ID: 16964262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection.
    Fischer H; Yamamoto M; Akira S; Beutler B; Svanborg C
    Eur J Immunol; 2006 Feb; 36(2):267-77. PubMed ID: 16385628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signalling of toll-like receptors.
    Brikos C; O'Neill LA
    Handb Exp Pharmacol; 2008; (183):21-50. PubMed ID: 18071653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate immune responses: crosstalk of signaling and regulation of gene transcription.
    Zhong B; Tien P; Shu HB
    Virology; 2006 Aug; 352(1):14-21. PubMed ID: 16753195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Troll in Toll: Mal and Tram as bridges for TLR2 and TLR4 signaling.
    Sheedy FJ; O'Neill LA
    J Leukoc Biol; 2007 Aug; 82(2):196-203. PubMed ID: 17449723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling.
    O'Neill LA; Bowie AG
    Nat Rev Immunol; 2007 May; 7(5):353-64. PubMed ID: 17457343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
    Miyazaki M; Kanto T; Inoue M; Itose I; Miyatake H; Sakakibara M; Yakushijin T; Kakita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    J Med Virol; 2008 Jun; 80(6):980-8. PubMed ID: 18428149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution and integration of innate immune recognition systems: the Toll-like receptors.
    Takeda K
    J Endotoxin Res; 2005; 11(1):51-5. PubMed ID: 15826379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages.
    Xu H; An H; Hou J; Han C; Wang P; Yu Y; Cao X
    Mol Immunol; 2008 Aug; 45(13):3545-52. PubMed ID: 18571728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules.
    Matsunaga N; Tsuchimori N; Matsumoto T; Ii M
    Mol Pharmacol; 2011 Jan; 79(1):34-41. PubMed ID: 20881006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expanding family of MyD88-like adaptors in Toll-like receptor signal transduction.
    McGettrick AF; O'Neill LA
    Mol Immunol; 2004 Jul; 41(6-7):577-82. PubMed ID: 15219996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role of toll-like receptors and nucleotide oligomerisation domain in the regulation of health and disease.
    Mitchell JA; Paul-Clark MJ; Clarke GW; McMaster SK; Cartwright N
    J Endocrinol; 2007 Jun; 193(3):323-30. PubMed ID: 17535871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral signaling through pattern recognition receptors.
    Kawai T; Akira S
    J Biochem; 2007 Feb; 141(2):137-45. PubMed ID: 17190786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAPPIT analysis of TLR adaptor complexes.
    Ulrichts P; Peelman F; Beyaert R; Tavernier J
    FEBS Lett; 2007 Feb; 581(4):629-36. PubMed ID: 17258210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.